Cyano-B12 or Whey Powder with Endogenous Hydroxo-B12 for Supplementation in B12 Deficient Lactovegetarians.

Icon for PubMed Central Related Articles

Cyano-B12 or Whey Powder with Endogenous Hydroxo-B12 for Supplementation in B12 Deficient Lactovegetarians.

Nutrients. 2019 Oct 06;11(10):

Authors: Naik S, Mahalle N, Greibe E, Ostenfeld MS, Heegaard CW, Nexo E, Fedosov SN

Abstract
Lactovegetarians (n = 35) with low vitamin B12 (B12) status were intervened for eight weeks capsules containing cyano-B12 (CN-B12), (2 ? 2.8 ?g/day), or equivalent doses of endogenous B12 (mainly hydroxo-B12 (HO-B12)) in whey powder. Blood samples were examined at baseline, every second week during the intervention, and two weeks post-intervention. The groups did not differ at baseline in [global median (min/max)] plasma B12 [112(61/185)] pmol/L, holotranscobalamin [20(4/99)] pmol/L, folate [13(11/16)], the metabolites total homocysteine [18(9/52)] ?mol/L and methylmalonic acid [0.90(0.28/2.5)] ?mol/L, and the combined indicator of B12 status (4cB12) [-1.7(-3.0/-0.33)]. Both supplements caused significant effects, though none of the biomarkers returned to normal values. Total plasma B12 showed a higher increase in the capsule group compared to the whey powder group (p = 0.02). However, the increase of plasma holotranscobalamin (p = 0.06) and the lowering of the metabolites (p > 0.07) were alike in both groups. Thereby, the high total plasma B12 in the capsule group was not mirrored in enhanced B12 metabolism, possibly because the B12 surplus was mainly accumulated on an “inert” carrier haptocorrin, considered to be of marginal importance for tissue delivery of B12. In conclusion, we demonstrate that administration of whey powder (HO-B12) or capsules (CN-B12) equivalent to 5.6 ?g of B12 daily for eight weeks similarly improves B12 status but does not normalize it. We document that the results for plasma B12 should be interpreted with caution following administration of CN-B12, since the change is disproportionately high compared to the responses of complementary biomarkers.

PMID: 31590426 [PubMed - indexed for MEDLINE]

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition.

Related Articles Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients. 2019 Oct 07;11(10): Authors: Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GAD, Gasbarrini A, Mele MC Abstract The gut microbiota is a changing ecosystem, containing trillions of bacteria, continuously shaped by many factors, such … Continue reading

Plant-Based Diets in CKD.

Related Articles Plant-Based Diets in CKD. Clin J Am Soc Nephrol. 2019 01 07;14(1):141-143 Authors: Clegg DJ, Hill Gallant KM PMID: 30587492 [PubMed - indexed for MEDLINE]

Hematological parameters and prevalence of anemia in white and British Indian vegetarians and nonvegetarians in the UK Biobank.

Related Articles Hematological parameters and prevalence of anemia in white and British Indian vegetarians and nonvegetarians in the UK Biobank. Am J Clin Nutr. 2019 08 01;110(2):461-472 Authors: Tong TYN, Key TJ, Gaitskell K, Green TJ, Guo W, Sanders TA, Bradbury KE Abstract BACKGROUND: There may be differences in hematological parameters between meat-eaters and vegetarians. … Continue reading

New Evaluation of Isoflavone Exposure in the French Population.

Related Articles New Evaluation of Isoflavone Exposure in the French Population. Nutrients. 2019 Sep 28;11(10): Authors: Lee A, Beaubernard L, Lamothe V, Bennetau-Pelissero C Abstract The study relates the present evaluation of exposure to estrogenic isoflavones of French consumers through two approaches: (1) identification of the isoflavone sources in the French food offering, (2) a … Continue reading

Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.

Related Articles Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 05;28(3):267-277 Authors: Goraya N, Wesson DE Abstract PURPOSE OF REVIEW: We review the growing clinical evidence that metabolic acidosis mediates chronic kidney disease (CKD) progression and that treatment to increase the associated low serum … Continue reading

Life Extension Membership